SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Thompson Bruce E

(Last) (First) (Middle)
3522 SW 92ND STREET

(Street)
GAINESVILLE FL 32608

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EXACTECH INC [ EXAC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Sr VP, Biologics & Spine
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2015
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/30/2015 A(1) V 359 A $14.82 23,139 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Incentive Stock Option (right to buy) $14.27 12/18/2011 12/18/2016 Common Stock 5,000 3,814 D
Incentive/Non-qualified Stock Option (right to buy) $17.02 02/16/2013 02/16/2016 Common Stock 25,000 22,804 D
Incentive/Non-Qualified Stock Option (right to buy) $18.95 02/28/2014 02/28/2017 Common Stock 5,900 5,900 D
Incentive/Non-Qualified Stock Option (right to buy) $16.33 02/22/2017(2) 02/22/2019 Common Stock 23,800 23,800 D
Incentive/Non-Qualified Stock Option (righ to buy) $18.55 02/25/2018(3) 02/25/2020 Common Stock 20,000 20,000 D
Non-Qualified Stock Option (right to buy) $20.9 05/09/2019(4) 05/09/2021 Common Stock 12,000 12,000 D
Non-Qualified Stock Option (right to buy) $23.28 04/29/2020(5) 04/29/2022 Common Stock 9,000 9,000 D
Explanation of Responses:
1. Such shared were acquired pursuant to the Issuer's 2009 Employee Stock Purchase Plan.
2. Such options are currently exercisable as regards 14,280 of the covered shares. The remaining options are exercisable, as regards 4,760 of the covered shares on the fourth anniversary of the date of grant, and as regards 4,760 of the covered shares, on the fifth anniversary of the date of grant.
3. Such options are currently exercisable as regards 8,000 of the covered shares. The remaining options are exercisable, as regards 4,000 of the covered shares, on the third anniversary of the date of grant, as regards 4,000 of the covered shares on the fourth anniversary of the date of grant, and as regards 4,000 of the covered shares, on the fifth anniversary of the date of grant.
4. Such options are currently exercisable as regards 2,400 of the covered shares. The remaining options are exercisable, as regards 2,400 of the covered shares, on the second anniversary of the date of grant, as regards 2,400 of the covered shares, on the third anniversary of the date of grant, as regards 2,400 of the covered shares on the fourth anniversary of the date of grant, and as regards 2,400 of the covered shares, on the fifth anniversary of the date of grant.
5. Such options are exercisable as regards 1,800 of the covered shares, on the first anniversary of the date of grant, as regards 1,800 of the covered shares, on the second anniversary of the date of grant, as regards 1,800 of the covered shares, on the third anniversary of the date of grant, as regards 1,800 of the covered shares on the fourth anniversary of the date of grant, and as regards 1,800 of the covered shares, on the fifth anniversary of the date of grant.
Remarks:
/s/ Bruce E. Thompson 10/02/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.